Galderma Group N

Galderma Group Nverified

GALD.SW

Price:

$166.6

Market Cap:

$39.12B

Galderma Group AG is engaged in cosmetic industry. Its segment includes Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology.

Industry

Household & Personal Products

IPO Date

2024-03-21

Stock Exchange

SIX

Ticker

GALD.SW

The ROE as of December 2025 (TTM) for Galderma Group N (GALD.SW) is 4.22%

According to Galderma Group N’s latest financial reports and current stock price. The company's current ROE is 4.22%. This represents a change of 249.06% compared to the average of 1.21% of the last 4 quarters.

Galderma Group N (GALD.SW) Historical ROE (quarterly & annually)

How has GALD.SW ROE performed in the past?

The mean historical ROE of Galderma Group N over the last ten years is -0.94%. The current 4.22% ROE has changed -546.98% with respect to the historical average. Over the past ten years (40 quarters), GALD.SW's ROE was at its highest in in the June 2025 quarter at 2.16%. The ROE was at its lowest in in the December 2023 quarter at -1.20%.

Quarterly (TTM)
Annual

Average

-0.94%

Median

-1.67%

Minimum

-3.40%

Maximum

2.97%

Galderma Group N (GALD.SW) ROE by Quarter and Year

Discovering the peaks and valleys of Galderma Group N ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual ROE = 2.97%

Minimum Annual Increase = -378.36%

Minimum Annual ROE = -3.40%

Quarterly (TTM)
Annual
YearROEChange
20242.97%-378.36%
2023-1.07%-53.18%
2022-2.28%-33.15%

Galderma Group N (GALD.SW) Average ROE

How has GALD.SW ROE performed in the past?

The current ROE of Galderma Group N (GALD.SW) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-0.13%

5-year avg

-0.94%

10-year avg

-0.94%

Galderma Group N (GALD.SW) ROE vs. Peers

How is GALD.SW’s ROE compared to its peers?

Galderma Group N’s ROE is less than Chocoladefabriken Lindt & Sprüngli AG (13.40%), less than Chocoladefabriken Lindt & Sprüngli AG (13.40%), less than Barry Callebaut AG (6.96%), less than Emmi AG (21.82%), less than Bell Food Group AG (7.78%), less than Groupe Minoteries S.A. (4.60%), less than Aryzta AG (16.85%), greater than Orior AG (-140.03%), less than Villars Holding S.A. (2.49%),

Build a custom stock screener for Galderma Group N (GALD.SW) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Galderma Group N using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Galderma Group N (GALD.SW) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Galderma Group N or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Galderma Group N's ROE?

How is the ROE calculated for Galderma Group N (GALD.SW)?

What is the highest ROE for Galderma Group N (GALD.SW)?

What is the 3-year average ROE for Galderma Group N (GALD.SW)?

What is the 5-year average ROE for Galderma Group N (GALD.SW)?

How does the current ROE for Galderma Group N (GALD.SW) compare to its historical average?